Analysis and application of an equilibrium model for in vitro bioassay systems with three components: Receptor, hormone and hormone-binding-protein

Journal of Theoretical Biology

Volumn 190, Issue 4, 1998, Pages 333-339

  Barnard, Ross ^a   Wolff, Rodney C ^b  

^a GPO Box 2434   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; HORMONE BINDING PROTEIN; RECEPTOR;

ALGORITHM; ARTICLE; BINDING AFFINITY; BIOASSAY; MODEL; PREDICTION; PRIORITY JOURNAL; RECEPTOR OCCUPANCY;

EID: 0032554320     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1997.0555     Document Type: Article

References (26)

1. BARNARD, R., NG, K. W., MARTIN, T. J. & WATERS, M. J. (1991). Growth hormone (GH) receptors in cloned osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 128, 1459-1464.
2. BARNARD, R. & WATERS, M. J. (1986) Serum and liver cytosolic growth-hormone binding proteins are antigenically identical with liver membrane 'receptor' types 1 and 2. Biochem J. 237, 885-892.
3. BELLEAU, B. (1964). A molecular theory of drug action based on induced conformational perturbations of receptors. J. Med. Chem. 7, 776-784.
4. BINDER, L., VOGEL, T., HADARY, D., ELBERG, G. & GERTLER, A. (1989). Chimeric bovine-human growth hormone prepared by recombinant DNA technology: binding properties and biological activity. Mol. Endocrinol. 3, 923-930.
5. CLARK, A. J. (1937). General pharmacology. In: Handbuch der Experimentellen Pharmakologie, supplement 4 (Heubner, W. & Schuller, J., eds), pp. 4-190. Berlin: Springer Verlag.
6. CONTRERAS, B. & TALAMANTES, F. (1996). In vitro growth hormone (GH) effects on the expression of growth hormone-binding protein (GHBP) in primary mouse hepatocytes cultured from day nine of pregnancy. Proceedings of the 10th International Congress of Endocrinology. San Francisco p. 490 (abstract).
7. CORY, A. H., OWEN, T. C., BARLSTROP, J. A. & CORY, J. G. (1991). Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3, 207-212.
8. CUNNINGHAM, B. C., ULTSCH, M., DE VOS, A. M., MULKERRIN, M. G., CLAUSER, K. R. & WELLS, J. A. (1991). Dimerization of the extracellular domain of the human growth hormone receptor by a single growth hormone molecule. Science 254, 821-825.
9. DATTANI, M. T., HINDMARSH, P. C., BROOK, C. G., ROBINSON, I. C. & MARSHALL, N. J. (1994). Inhibition of growth hormone bioactivity by recombinant human growth-hormone-binding-protein in the eluted stain assay system. J. Endocrinol. 140, 445-453.
10. DRUMMOND, A. E., MCPHERSON, S. J., LASLETT, A. & HEARN, M. T. W. (1996). Application of a chromogenic bioassay procedure for the measurement of the proliferation of endothelial cells in vitro under the influence of the effects of steroid hormones and growth factors. J. Biochem. Biophys. Methods 31, 123-134.
11. FUH, G., CUNNINGHAM, B. C., FUKUNAGA, R., NAGATA, S., GOEDDEL, D. V. & WELLS, J. A. (1992). Rational design of potent antagonists to the human growth hormone receptor. Science 256, 1677-1680.
12. GIENI, R. S., LI, Y., & HAYGLASS, K. T. (1995). Comparison of [3H]-thymidine incorporation with MTT- and MTS- based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. J. Immunol. Meth. 187, 85-93.
13. HANSEN, B. S., HJORTH, S., WELINDER, B. S., SKRIVER, L. & DE MEYTS, P. (1993). The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Endocrinology 133, 2809-2817.
14. HAPEL, A. J., WARREN, H. S. & HUME, D. A. (1984). Different colony stimulating factors are detected by the interleukin 3-dependent cell lines FDC-P1 and 32D-C1 23. Blood 64, 786-790.
15. HARRISON, S. M., BARNARD, R., HO, K. Y., RAJKOVIC, I. & WATERS, M. J. (1995). Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor. Endocrinology 136, 651-659.
16. LEFF, P. & HARPER, D. (1989). Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates? J. theor. Biol. 140, 381-397.
17. LIM, L., SPENCER, S. A., MCKAY, P. & WATERS, M. J. (1990). Regulation of growth-hormone (GH) bioactivity by a recombinant human GH binding protein. Endocrinology 127, 1287-1291.
18. MANNOR, D. A., WINER, L. M., SHAW, M. A. & BAUMANN, G. (1991). Plasma growth-hormone (GH)-binding proteins: effect on GH binding to receptors and GH action. J. Clin. Endocrinol. Metab. 73, 30-34.
19. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Meth. 65, 55-63.
20. MULLBERG, J., SCHOOLTINK, H., STOYAN, T., GUNTHER, M., GRAEVE, L., BUSE, G., et al. (1993). The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23, 473-480.
21. NARAZAKI, M., YASUKAWA, K., SAITO, T., OHSUGI, Y., FUKUI, H., KOISHIHARA, Y., et al. (1993). Soluble forms of the interleukin-6 signal transducing receptor component gp 130 in human serum possessing a potential to inhibit signals through membrane-anchored gp 130. Blood 82, 1120-1126.
22. ROWLINSON, S. W., BARNARD, R., BASTIRAS, S., ROBINS, A. J., BRINKWORTH, R. & WATERS, M. J. (1995). A growth hormone agonist produced by targetted mutagenesis at binding site 1. Evidence that site 1 regulates bioactivity. J. Biol. Chem. 270, 16833-16839.
23. SCUDIERO, D. A., SHOEMAKER, R. H., PAULL, K. D., MONKS, A., TIERNEY, S., NOFZIGER, T. H., et al. (1988). Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833.
24. SINGH, A., PUROHIT, A., WANG, Y., DUNCAN, L. J., GHILCHIK, M. W. & REED, M. J. (1995). IL-6 sR: release from MCF-7 breast cancer cells and role in regulating peripheral oestrogen synthesis. J. Endocrinol. 147, R9-R12.
25. TADA, H., SHIHO, O., KUROSHIMA, K., KOYAMA, M. & TSUKAMOTO, K. (1986). An improved colorimetric assay for interleukin 2. J. Immunol. Meth. 93, 157-165.
26. YASUKAWA, K., SAITO, T., FUKUNAGA, T., SEKIMORI, Y., KOISHIHARA, Y., FUKUI, H., et al. (1990). Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J. Biochem. 108, 673-676.